GlassScriptPhysician profile
Christine Bowie
NPI 1285473553
$1,458.65
in general payments reported to CMS, 2019-2025
17 companies · $1,420 in 2025
The $1,420 reported for 2025 was more than what 87% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38.62 · 2025: $1,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $302.81 | 2025 | Austedo Xr, Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $236.26 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $190.40 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $171.10 | 2025 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $109.43 | 2025 | |
| Alkermes, INC. | $78.34 | 2025 | Aristada, Lybalvi |
| Acadia Pharmaceuticals INC | $61.91 | 2025 | Nuplazid |
| Takeda Pharmaceuticals U.S.A., INC. | $60.51 | 2025 | Trintellix |
| Abbvie INC. | $48.88 | 2025 | |
| Lundbeck LLC | $43.91 | 2025 | Rexulti |
| Noven Therapeutics, LLC | $39.89 | 2025 | Xelstrym |
| Vanda Pharmaceuticals INC. | $23.93 | 2025 | Fanapt, Hetlioz |
| Ironshore Pharmaceuticals INC. | $22.05 | 2024 | |
| Corium, LLC | $19.77 | 2025 | Azstarys |
| Lilly USA, LLC | $16.96 | 2025 | Kisunla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $16.57 | 2024 | Rexulti |
| Collegium Pharmaceutical, INC. | $15.93 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Bowie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.